The Value of Diagnostics in Combating the Public Health Problem of Antimicrobial Resistance

Decorative image of the AMR Learning Lounge

The Value of Diagnostics in Combating the Public Health Problem of Antimicrobial Resistance

SUMMARY

World AMR Congress | November 9, 2021

During his keynote address at the 2021 World AMR Congress, pharmacist and adjunct professor Tristan Timbrook overviews the issue of antimicrobial resistance (AMR) at both a patient and population health level and explains the role of rapid diagnostics in improving antimicrobial stewardship (ASP). Coordinated efforts and a "One Health" approach are required for population level improvements as stewards consider the impact of AMR on people, animals, and the environment when optimizing antimicrobial use.

FEATURED EXPERTS

Tristan Timbrook, PharmD, BCPS, Director of Health Economics and Outcomes Research, Global Medical Affairs, bioMérieux and Adjunct Assistant Professor at the University of Utah College of Pharmacy

GET STARTED

Missed the conference? Download Tristan's keynote presentation (PPT) here.

Download the Presentation

Filename: 2021-World-AMR-Congress_keynote_Tristan-Timbrook_LL-v-F_November.pdf
Size: 1 MB
Format: application/pdf

Estimated reading time: 5 minutes

We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.

Take Our Poll

US Solutions

Accelerate Antimicrobial Stewardship Program Success

Diagnostics are at the heart of antimicrobial stewardship. Their core value exists outside the lab, providing actionable data to the patient care team. With our collaborative stewardship consultancy, discover opportunities to unlock the full potential of Diagnostics and Antimicrobial Stewardship and foster a mindset of continuous action, engagement, and improvement.

Learn More